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Abstract — Aims: To determine whether the functional polymorphism −592C>A of the interleukin (IL)-10 gene (IL10) influences
the development of alcoholic liver disease or alcoholism in alcoholic Spanish subjects. Methods: The −592C>A IL10 polymorphism
was analyzed by the polymerase chain reaction and digestion with restriction enzymes in 257 male alcoholics [161 without alcoholic
liver disease and 96 with alcoholic liver cirrhosis (ALC)] and 100 male healthy controls. Results: We found no association between
the −592C>A IL10 polymorphism and ALC. Meta-analysis combining this result and data from previous studies failed also to show
any significant association between this polymorphism and alcoholic liver disease. However, the frequency of allele A carriers (CA
and AA genotypes) was significantly higher in alcoholic patients (defined as patients with abuse or dependence of alcohol) than in
healthy controls. Conclusion: The −592C>A IL10 polymorphism is not related to the risk of ALC. Nevertheless, our study shows that
alcoholism is associated with an excess of allele A carriers in alcoholic patients.
INTRODUCTION
At present, there is strong evidence that genetic factors could
play an important role in the susceptibility to alcoholic liver
cirrhosis (ALC) (Reed et al., 1996; Stickel and Osterre-
icher, 2006). An increased production of inflammatory cy-
tokines, such as interleukin-1 (IL-1) and tumor necrosis factor-
α (TNF-α), has been involved in the pathogenesis of liver
injury in chronic alcoholism (McClain et al., 2004; Crews
etal.,2006;Lasoetal.,2007b,2007a).Someauthors,basedon
results from animal models, have also suggested that elevated
circulating levels of TNF-α may lead to progressive neuroin-
flammationanddegenerationofbrain,whichcouldbeinvolved
in the development of alcohol dependence (Lin et al., 1998;
Crewsetal.,2006;Qinetal.,2007).Inlinewiththesefindings,
certainpolymorphismsingenesencodingIL-1andTNF-α have
been associated either with alcoholic liver disease or with al-
coholism (Takamatsu et al., 2000; Pastor et al., 2005a, 2005b).
Decreased levels of IL-10, a cytokine that inhibits the secre-
tion of TNF-α (Wang et al., 1994), have been shown in patients
with ALC (McClain and Cohen, 1989; Le Moine et al., 1995;
McClain et al., 2004; Crews et al., 2006). Moreover, IL-10
knockout mice are more sensitive to develop alcoholic liver
damage (Hill et al., 2002; Zhong et al., 2006).
In recent years, the relationship between alcoholic liver
disease and polymorphisms at positions −1082 (G>A,
rs1800896) (Bathgate et al., 2000; Grove et al., 2000; Ladero
et al., 2002; Richardet et al., 2006), −819 (C>T, rs1800871)
(Ladero et al., 2002) and −592 (C>A, rs1800896, also called
by others −597 or −627) (Grove et al., 2000; Ladero et al.,
2002; Martins et al., 2005; Richardet et al., 2006) in the pro-
moter region of the IL-10 gene (IL10) has been analyzed, al-
though a clear role for these genetic variants is not established.
Two common haplotypes, called ATA and GCC (Lim et al.,
1998; Edwards-Smith et al., 1999), are defined by these three
polymorphisms. Secretion of IL-10 in ATA haplotype is lower
than that in GCC haplotype (Lim et al., 1998; Edwards-Smith
et al., 1999; Hoffmann et al., 2001; Zhang et al., 2007). Due
to the strong linkage disequilibrium showed by these polymor-
phisms, the possession of the −592A allele could fully deter-
mine the presence of the common ATA haplotype (Lin et al.,
2003).
In the present study, we analyze if there is a relationship
between the −592C>A polymorphism of IL10 and either ALC
or alcoholism in chronic alcoholic Spanish men. Additionally,
we perform a meta-analysis of both our data and data from
previousstudiesinwhichthispolymorphismhasbeenanalyzed
in patients with alcoholic liver disease.
PATIENT AND METHODS
Subjects
We studied 257 male alcoholic patients referred to the Al-
coholism Unit of the University Hospital of Salamanca
(Salamanca, Spain). The patients were aged between 24 and
80 years (52.15 ± 12.56 years, mean ± SE) and had consumed
>120 g of ethanol daily for at least 10 years. Of them, 161
were alcoholics without alcoholic liver disease (48.45 ± 11.42
years, AWLD group), whereas 96 patients were diagnosed as
having ALC (58.26 ± 12.00 years, ALC group). All patients
met criteria for alcohol abuse or dependence according to the
DSM-IVcriteriaandtheywerediagnosedbyapsychiatristspe-
cialized in treatment of alcoholism. Ninety-seven patients had
alcohol abuse (41 with ALC and 56 in the AWLD group) and
160patientshadalcoholdependence(55and105,respectively)
(American Psychiatric Association, 2000).
Histopathological examination of the liver of 87 cirrhotic
patients in which liver biopsy was performed revealed micron-
odular cirrhosis. This test was not performed in the remaining
nine patients due to coagulation abnormalities. In these cases,
the diagnosis of liver cirrhosis was established on the basis
of the presence of the physical stigmata of chronic liver dis-
ease (i.e. cutaneous signs, hepatosplenomegaly, gynecomastia,
C   The Author 2008. Published by Oxford University Press on behalf of Medical Council on Alcohol. All rights reserved
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testicular atrophy), a history of ascites, variceal bleeding or
hepatic encephalopathy, as well as on gastroscopic and/or ul-
trasonographic findings (Erlinger and Benhamou, 1999).
AWLD patients had no clinical evidence of liver disease,
normal liver blood tests [with the exception of an isolated rise
ingamma-glutamyltransferaseasanalcoholintakemarker(Wu
et al., 1976)] and normal liver ultrasonography. Alcoholic pa-
tients presenting abnormalities in liver blood tests (bilirrubin,
transaminsases or alkaline phosphatase), in which liver biopsy
was not clinically indicated, were excluded from this study. In
this group of patients performing a liver biopsy was not con-
sidered ethically justifiable, and therefore it was impossible to
classify these individuals as suffering from ALC or not having
liver damage.
Hepatitis B surface antigen and antibodies to hepatitis C
virus were negative in all the alcoholic patients; other causes of
chronic liver disease, such as hemochromatosis or autoimmune
liver disease, were excluded using standard tests.
One hundred sex-matched healthy volunteers were included
in the study (41.04 ± 12.56 years). All of them consumed
<10 g of ethanol per day and none had a history of alcohol
abuseoralcoholdependenceandneitherdidtheirfirstorsecond
degree relatives.
AllpatientsandcontrolsubjectswerefromCastillaandLe´ on
(northwestern Spain) as were their parents and grandparents
and were all from Caucasian origin. All subjects gave informed
consenttoparticipate,andthestudywasapprovedbytheEthics
Committee of the University Hospital of Salamanca.
Genetic analyses
Genomic DNA was extracted from nucleated peripheral blood
cellsusingstandardproteinaseKdigestion,phenol–chloroform
extraction and ethanol precipitation and was stored at −20◦C.
IL10 polymorphism was detected using the follow-
ing primers: 5 -CCTAGGTCACAGTGACGTGG-3  and 5 -
GGTGAGCACTACCTGACTAGC-3 .D N As a m p l e sw e r e
amplified in a 50 µl reaction volume that contained 45 µl
of polymerase chain reaction (PCR) Supermix (Life Promega
Technologies, Eggenstein, Germany), 4 µl of the above-
described primers at 0.1 mg/ml and 500 ng of the DNA sample.
PCR conditions consisted of a denaturation step at 94◦Cf o r
5 min and then 35 cycles of denaturation at 94◦C for 30 s,
annealing at 52◦C for 30 s and extension at 72◦C for 30 s,
with a final extension step at 72◦C for 10 min. The PCR am-
plification yielded a fragment of 412 bp electrophoresed on
2.5% agarose gels with ethidium bromide staining. After its
digestion overnight at 37◦C with AfaI, the fragments obtained
(of 412, 236 and 176 bp) were separated on 2.5% agarose gel
electrophoresis, stained with ethidium bromide and visualized
with ultraviolet light. If the nucleotide −592 was C, the PCR
fragment remained uncut (412 bp), but if the nucleotide −592
was A, we obtained two PCR fragments (236 and 176 bp).
Statistical analysis
The Student’s t and χ2 tests were used for the comparison of
quantitative and qualitative variables, respectively. The devia-
tion of genotype frequencies from the Hardy–Weinberg equi-
librium in healthy subjects was assessed by the χ2 test. Carrier
and genotypic frequencies among groups were compared by
means of the χ2 test and Fisher’s exact test when necessary
(expected values below 5). The odds ratio (OR) and 95% confi-
denceintervals(95%CI)werealsocalculated.AP-value<0.05
was regarded as significant. All these analyses were performed
using the software program SPSS 12.0 (Chicago, IL, USA).
Meta-analysis
All studies published before November 2007 were identified
by searching the PubMed database, using the following entries
as a search criterion: polymorphism, interleukin-10 and alco-
holism, alcohol or alcoholic liver disease. Case-control studies
that analyzed the distribution of the −592C>A IL10 polymor-
phism in alcoholic liver disease were eligible for inclusion. We
considered as cases patients with heavy alcohol intake (>80 g
of ethanol/day for at least 5 years) with histological diagnosis
of ALC or alcoholic hepatitis, as well as patients with ALC
diagnosed by clinical, ultrasonography and gastroscopic find-
ings. Controls were defined as individuals with heavy alcohol
intake but without alcoholic liver disease or with simple steato-
sis diagnosed by liver biopsy. Allelic and genotypic frequency
wereextractedorcalculatedfrompublisheddata.Bibliographic
search and data extraction were done independently by two au-
thors (M. M. and F. J. L.), and consensus was achieved for all
data. As previous data (Grove et al., 2000) and our own results
suggested that the effect of the A allele was dominant, the main
meta-analysisstudiedtheassociationbetweenthepossessionof
the A allele and the risk of alcoholic liver disease; the recessive
contrast of the allele A was also examined. We also performed
anexploratorymeta-analysisanalyzingtheassociationbetween
the possession of the A allele and the risk of an excessive al-
cohol intake. The OR and its 95% CI were estimated for each
study. Cochran’s Q-statistic was used to assess heterogeneity: a
significantQ-statistic(P<0.10)indicatedheterogeneityacross
studies, and therefore the random effect model (DerSimonian
and Laird) was used for meta-analysis; otherwise, fixed effect
model (Mantel–Haenszel) was used. A sensitivity analysis was
performed examining the effect of excluding specific studies
(Cochran, 1954; Davey Smith and Egger, 1997). The meta-
analysis was carried out using the computer software package
RevMan 4.2.8 (RevMan Analyses, 2003).
RESULTS
Analysis of the −592C>A IL10 polymorphism
The distribution of −592C>A IL10 genotypes in control sub-
jects were similar to that previously published for Caucasians
(Groveetal.,2000;Laderoetal.,2002)anddidnotsignificantly
differ from those expected from Hardy–Weinberg equilibrium
(χ2 = 1.508; P = 0.219).
Genotypic and allelic distribution of the −592C>A IL10
polymorphism are summarized in Table 1. We did not observe
any statistical difference when we compared the groups of pa-
tients with the presence or absence of alcoholic liver disease.
However, the frequency of allele A carriers was significantly
higher in alcoholic patients than in healthy subjects (52.1 and
40.0%, respectively; P = 0.039). The possession of the A al-
lele (CA and AA genotypes) conferred an OR of 1.25 (95% CI
1.02–1.54; P = 0.039) for the presence of alcoholism.
b
y
 
g
u
e
s
t
 
o
n
 
N
o
v
e
m
b
e
r
 
6
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 Interleukin-10 Polymorphism and Alcoholism 525
Table 1. Distribution of the −592C>A IL-10 gene polymorphism in alcoholic patients and healthy subjects
Subjects Genotypic frequency (%) Allelic carriers (%)
CC CA AA CC + CA CA + AA
Total (n = 357) 183 (51.3%) 144 (40.3%) 30 (8.4%) 327 (91.6%) 174 (48.7%)
Alcoholics (n = 257) 123 (47.9%) 112 (43.6%) 22 (8.6%) 235 (91.4%) 134 (52.1%)∗
AWLD group (n = 161) 77 (47.8%) 68 (48.2%) 16 (9.9%) 145 (90.1%) 84 (52.2%)
ALC group (n = 96) 46 (47.9%) 44 (45.8%) 6 (6.3%) 90 (93.8%) 50 (52.1%)
Healthy subjects (n = 100) 60 (60.0%) 32 (32.0%) 8 (8.0%) 92 (92.0%) 40 (40.0%)∗
∗Odds ratio (95% confidence interval) for the possession of one or two A alleles in alcoholics versus healthy subjects: 1.25 (1.02–1.54); P = 0.039.
ALC, alcoholics with liver cirrhosis; AWLD, alcoholics without liver disease.
Table 2. Characteristics of the studies considered in the meta-analysis of the −592C>A polymorphism of the IL-10 gene in alcoholic liver disease
First author, year Selection criteria of cases and controls and genotype distribution
Grove et al., 2000 Patients with alcohol intake > 80 g/day for >10 years:
Cases: patients with liver histology compatible with ALD of greater severity than simple steatosis, or clinical evidence of hepatic
decompensation (N = 287; CC = 143, CA = 125, AA = 19)
Controls: patients without clinical or biochemical evidence of ALD or with liver histology showing either normal liver or steatosis
with no evidence of steatohepatitis or fibrosis (N = 107; CC = 68, CA = 125, AA = 3)
Healthy subjects: N = 227; CC = 152, CA = 70, AA = 5
Ladero et al., 2002 Cases: patients with ALC diagnosed either by histology or by unequivocal clinical, ultrasonographic or endoscopic findings and
with alcohol consume > 80 g/day for >10 years with (N = 143; CC = 89, CA = 43, AA = 11).
Controls: healthy subjects (N = 293; CC = 170, CA = 103, AA = 20)
Richardet et al., 2006 Cases: patients with alcohol intake >80 g/day for at least one year hospitalized with histological evidence of alcoholic hepatitis (N
= 134; CC = 77, CA = 51, AA = 6)
Controls: healthy subjects with daily alcohol intake <2 0g( N = 145; CC = 82, CA = 54, AA = 9)
Martins et al., 2005 Patients with alcohol intake >80 g/day for >5 years
Cases: patients with liver histology compatible with ALD of greater severity than simple steatosis, or clinical evidence of hepatic
decompensation (N = 100; CC = 57, CA = 34, AA = 8)
Controls: patients without clinical or biochemical evidence of ALD (N = 76; CC = 38, CA = 30, AA = 8)
N = subjects in each group; CC, CA and AA = subjects with CC, CA and AA genotype, respectively.
ALC, alcoholic liver cirrhosis; ALD, alcoholic liver disease.
Fig. 1. Meta-analysis of whether the possession of the A allele of the −592C>A IL10 polymorphism is related to the risk of alcoholic liver disease. Each study
is shown by an OR estimate with the corresponding 95% CI.
Meta-analysis of the −592C>A IL10 polymorphism
We identified four articles that met the search criteria, sum-
marized in Table 2. The studies from Grove et al. (2000) and
Martins et al. (2005) analyzed the termed ‘−627A’ allele, and
the one from Ladero et al. (2002) analyzed the ‘−597A’ al-
lele, both corresponding to the allele at position −592 bp from
the transcription start site, according to the published sequence
(Eskdale et al., 1997). However, as the works of Ladero et al.
(2002) and Richardet et al. (2006) did not provide data about
alcoholic patients without liver damage, we could not include
that studies in our meta-analysis. Therefore, the meta-analysis
was performed with the data from Grove et al. (2000), Mar-
tins et al. (2005) and our own data; no statistical differences
were observed in the distribution of A allele carriers between
alcoholics with or without liver disease (Fig. 1). The sensi-
tivity analysis did not alter the pattern of results. In addition,
we analyzed the effect of the A allele under a recessive model
(comparing the AA genotype with the CA and CC genotypes
combined), and we did not find any statistical relationship with
the presence of alcoholic liver disease (data not shown).
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Fig. 2. Meta-analysis of whether the possession of the A allele of the −592C>A IL10 polymorphism is related to the risk of a higher alcohol intake (>80 g/day
for at least 1 year). Each study is shown by an OR estimate with the corresponding 95% CI.
Regarding the relationship between −592C>A IL10 poly-
morphism and excessive alcohol intake, we performed a meta-
analysis extracting data from the work of Grove et al. (2000),
Ladero et al. (2002), Richardet et al. (2006) and our own work,
in order to compare patients with an alcohol intake >80 g/day
for at least 1 year with healthy subjects with an alcohol in-
take <20 g/day. This meta-analysis did not show a significant
relationship (Fig. 2).
DISCUSSION
It is well established that only a minority of alcoholic patients
have ALC; furthermore, alcoholic patients may or may not
develop alcohol dependence or alcohol abuse. In an attempt
to explain these findings, genetic studies have been conducted
and previous reports have shown that polymorphic alleles of
genesencoding inflammatorycytokines suchasIL-1andTNF-
α could change the susceptibility of chronic alcoholic patients
to develop ALC (Takamatsu et al., 2000; Pastor et al., 2005a).
Additionally, a strong association between advanced alcoholic
liver disease and the possession of the A allele in the promoter
region of the IL-10 cytokine gene has been reported (Grove
et al., 2000). These results, together with the data showing a
reduced IL-10 secretion in patients with the −592A allele of
this gene (Crawley et al., 1999; Hoffmann et al., 2001) as well
as the pathophysiologic role of IL-10 in alcoholic liver injury
(Hilletal.,2002;Zhongetal.,2006),raisedthehypothesisthat
this allelic variant could be involved in the development of this
disease.
As shown in Table 1 and Fig. 1, however, our results and
the meta-analysis performed indicate that ALC is not associ-
ated with the distribution of −592C>A IL-10 gene polymor-
phism. In addition to this, the studies from Ladero et al. (2002)
and Richardet et al. (2006), not included in our meta-analysis,
also showed a similar distribution of the −592A allele in pa-
tients with advanced alcoholic liver disease with respect to
controls. Interestingly Spanish alcoholics patients (defined as
patients with alcohol abuse or dependence) showed a signifi-
cantlyhigherfrequencyoftheAalleleincomparisontocontrol
subjects (Table 1).
Concerning genetic association studies, a number of poten-
tial biases may explain the disagreement between our results
and those from Martins et al. (2005) compared with the study
from Grove et al. (2000). The importance of genetic and clini-
calheterogeneityaswellaspopulationstratificationaspossible
biases in association studies has been described in detail else-
where (Hoffmann et al., 2001; Colhoun et al., 2003). Our study
also raises another potential methodological problem concern-
ing genetic studies in alcoholic liver disease: the possibility of
alcoholism acting as a confounding factor. One of the inclusion
criteria in our study was the presence of alcohol use disorders
(alcohol abuse or dependence), which allows us to control the
possible influence of these disorders in the development of al-
coholic liver damage (Wodak et al., 1983; Grant and Harford,
1988; Barrio et al., 2004) and to investigate the relationship
of IL10 with alcoholism by itself. In contrast, the article from
Grove etal.(2000)included‘heavydrinkers’(Table2)ascases
andcontrols,withoutconsideringthediagnosisofalcoholabuse
or dependence. Therefore, the higher frequency of the A allele
inpatientswithALDfoundinthisstudymayhavebeenduetoa
higher frequency of patients with alcohol abuse or dependence
in the group of patients with ALD.
An important issue in studies regarding alcoholic liver dis-
ease is the adequate selection of alcoholics who have not de-
veloped liver disease, given that performing a liver biopsy in
patients with normal liver blood tests may be unethical. A pre-
vious biopsy study in asymptomatic alcoholics with normal
blood tests showed that only a small percentage (4 of 85) of
them had features of alcoholic hepatitis or cirrhosis (Bruguera
et al., 1977). In view of both these data and ethical concerns,
our study design seems reasonable and is similar as in other
published articles (Grove et al., 2000; Martins et al., 2005).
Another potential limitation of our work is the small number of
studies that could be included in our meta-analysis. Nonethe-
less, this statistical method represents an evidence-based sys-
tematic approach and is the most accurate way of combining
previous results (Egger and Smith, 1997).
Regarding the association found in our study between the
−592A allele of IL-10 gene and alcoholism defined as alco-
hol abuse or dependence, we must admit that its functional
role is uncertain. Considering both the lower secretion of IL-10
in patients with the A allele (Crawley et al., 1999; Hoffmann
et al., 2001) and the inhibitory effects of IL-10 on TNF-α
secretion (Wang et al., 1994), also shown in rodent microglia
(Sawada et al., 1999; Kremlev and Palmer, 2005), our re-
sults support the notion that increased brain levels of TNF-α
could reduce glutamate transport, inducing a hyperglutamater-
gic state that activates limbic dopamine and promotes neu-
rotoxicity and alcohol consumption (Crews et al., 2006). In
line with this, recent work conducted by our group has shown
the association of IL-1 gene polymorphisms and alcoholism
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(Pastor et al., 2005b). Overall, these findings show a genetic
association between alcoholism and genes that encode proteins
involved in the immune response, although the exact relation-
ship of the −592C>A polymorphism with alcoholism must
be further investigated, given the possibility of a type I error
and the lack of association found in the meta-analysis per-
formed to analyze the relationship between the A allele and
the risk of excessive alcohol intake. We must also consider that
the studies integrated in this meta-analysis lack both homoge-
neous criteria for ‘excessive alcohol intake’ and alcohol use
disorder diagnosis, which makes it more difficult to reach a
conclusion about the association between alcoholism and this
polymorphism.
Insummary,thepresentstudyshowsthatalcoholism,butnot
ALC, is associated with the −592C>A polymorphism of the
IL-10 gene. Moreover, due to the possibility that alcoholism
may be a confounding factor for alcoholic liver disease in ge-
netic association studies, its presence should be controlled in
further candidate gene studies regarding this disease.
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